In a federal lawsuit filed in the U.S. District Court for the District of Columbia, Masimo (MASI) claimed the U.S. Customs and Border Protection, CBP, unlawfully allowed Apple (AAPL) to reactivate a blood-oxygen tracking feature on its Apple Watches, a feature that infringes on patents for the technology, Christopher Yasiejko of Bloomberg Law reports. Masimo said the CBP quietly reversed its decision without hearing both sides on the topic.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MASI: